Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.

Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.

Item
http://www.wikidata.org/entity/Q38862502
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-RasG12V-Induced Squamous Tumors.M2-Polarized Macrophages Compose Lupus Vulgaris Arising from a Bacillus Calmette-Guérin Vaccination Site.Sarcoidosis-Lymphoma Syndrome Associated with Folliculotropic Peripheral T Cell Lymphoma Not Otherwise Specified.Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy.Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile Dermatomyositis.Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes.Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration
P2860

Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.

Item
http://www.wikidata.org/entity/Q38862502
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.
@en
type
label
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.
@en
prefLabel
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.
@en
P2093
P304
P31
P356
10.1016/J.JDERMSCI.2016.05.015
P433
P478
P577
P698
P921